Kathy Fay Mahdoubi, reported, “In a review of available PET imaging biomarkers that focus on cellular proliferation as an important key to cancer detection and therapy monitoring, F-18 FLT stood out as a game-changer for its ability to hone in on processes specific to cancer growth. However, in many studies, tracer uptake was underwhelming when compared to standard FDG, according to a scientific paper published May 14 in the Journal of Nuclear Medicine .”